Tretinoin peel: a critical view

Area of Science:

• Dermatology
• Chemical Peels
• Retinoids

Background:

• Tretinoin (retinoic acid) is a topical retinoid used for various skin conditions.
• The tretinoin peel, a superficial chemical peel, has been explored since 2001, primarily in Brazil.
• While studies suggest benefits for melasma and skin aging, a robust scientific consensus is lacking.

Purpose of the Study:

• To review existing literature on topical tretinoin as a superficial chemical peeling agent.
• To evaluate the reported benefits and limitations of tretinoin peels.
• To identify areas for future research to establish evidence-based protocols.

Main Methods:

• Literature review of studies evaluating topical tretinoin for superficial chemical peels.
• Analysis of reported outcomes for dermatological conditions, particularly melasma and skin aging.
• Assessment of study methodologies regarding concentration, vehicle, and treatment regimens.

Main Results:

• Most reviewed studies indicate positive outcomes for tretinoin peels in treating melasma and signs of skin aging.
• The scientific background and consensus on tretinoin peels remain inconsistent.
• Methodological limitations were noted in several studies, impacting the reliability of findings.

Conclusions:

• Topical tretinoin demonstrates potential as a superficial chemical peel for melasma and photoaging.
• Improved study design quality, including standardized concentrations, vehicles, and treatment schedules, is essential.
• Controlled, randomized studies comparing tretinoin cream versus peel application are necessary to solidify its role in dermatological treatments.